<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9111820</journal-id>
<journal-id journal-id-type="pubmed-jr-id">21573</journal-id>
<journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. Psychiatry</journal-id>
<journal-title-group>
<journal-title>European psychiatry : the journal of the Association of European Psychiatrists</journal-title>
</journal-title-group>
<issn pub-type="ppub">0924-9338</issn>
<issn pub-type="epub">1778-3585</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28365467</article-id>
<article-id pub-id-type="pmc">5507360</article-id>
<article-id pub-id-type="doi">10.1016/j.eurpsy.2017.02.479</article-id>
<article-id pub-id-type="manuscript">NIHMS864965</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Lipidome in Major Depressive Disorder: Shared Genetic Influence for Ether-Phosphatidylcholines, a Plasma-Based Phenotype Related to Inflammation, and Disease Risk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Knowles</surname>
<given-names>Emma E. M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huynh</surname>
<given-names>Kevin</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meikle</surname>
<given-names>Peter J</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harald</surname>
<given-names>H. H. Goring</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olvera</surname>
<given-names>Rene L.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mathias</surname>
<given-names>Samuel R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duggirala</surname>
<given-names>Ravi</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Almasy</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blangero</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Curran</surname>
<given-names>Joanne E.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glahn</surname>
<given-names>David C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">5</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA</aff>
<aff id="A2">
<label>2</label>Baker IDI Heart and Diabetes Institute, Melbourne, Australia</aff>
<aff id="A3">
<label>3</label>South Texas Diabetes and Obesity Institute, University of Texas Health Science Center at San, Antonio &amp; University of Texas of the Rio Grande Valley, Brownsville, TX, USA</aff>
<aff id="A4">
<label>5</label>Olin Neuropsychiatric Research Center, Institute of Living, Hartford Hospital, Hartford, CT, USA</aff>
<author-notes>
<fn fn-type="COI-statement" id="FN1">
<p><bold>Conflicts of Interest:</bold> none.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2018</year>
</pub-date>
<volume>43</volume>
<fpage>44</fpage>
<lpage>50</lpage>
<!--elocation-id from pubmed: 10.1016/j.eurpsy.2017.02.479-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P2">The lipidome is rapidly garnering interest in the field of psychiatry. Recent studies have implicated lipidomic changes across numerous psychiatric disorders. In particular there is growing evidence that the concentrations of several classes of lipids are altered in those diagnosed with MDD. However, for lipidomic abnormalities to be considered potential treatment targets for MDD (rather than secondary manifestations of the disease), a shared etiology between lipid concentrations and MDD should be demonstrated.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P3">In a sample of 567 individuals from 37 extended pedigrees (average size 13.57 people, range = 3â€“80), we used mass-spectrometry lipidomic measures to evaluate the genetic overlap between twenty-three biologically distinct lipid classes and a dimensional scale of MDD.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">We found that the lipid class with the largest endophenotype ranking value (ERV, a standardized parametric measure of pleiotropy) were ether-phosphodatidylcholines (alkylphosphatidylcholine, PC(O) and alkenylphosphatidylcholine, PC(P) subclasses). Furthermore, we examined the cluster structure of the twenty-five species within the top-ranked lipid class, and the relationship of those clusters with MDD. This analysis revealed that species containing arachidonic acid generally exhibited the greatest degree of genetic overlap with MDD.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P5">Thisstudy is the first to demonstrate a shared genetic etiology between MDD and ether-phosphatidylcholine species containing arachidonic acid, an omega-6 fatty acid that is a precursor to inflammatory mediators, such as prostaglandins. The study highlights the potential utility of the well-characterized linoleic/arachidonic acid inflammation pathway as a diagnostic marker and/or treatment target for MDD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Affective Disorders</kwd>
<kwd>Unipolar Depression</kwd>
<kwd>Genetics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>